Molecular mechanisms involved in adenosine-induced endothelial cell barrier enhancement

Vascular Pharmacology

Volumn 52, Issue 5-6, 2010, Pages 199-206

  Umapathy, Nagavedi S ^a   Fan, ZhengHong ^a   Zemskov, Evgeny A ^a   Alieva, Irina B ^a   Black, Stephen M ^a   Verin, Alexander D ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Anti inflammation; Human pulmonary artery endothelial cells; Myosin light chain phosphatase; P1 receptor agonists

Indexed keywords

ADENOSINE; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; F ACTIN; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; MYOSIN LIGHT CHAIN PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 2A; SMALL INTERFERING RNA; VASCULAR ENDOTHELIAL CADHERIN;

ARTICLE; CELL JUNCTION; CELL MEMBRANE; CELL SURFACE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSKELETON; ELECTRIC RESISTANCE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LUNG ARTERY; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; TRANSENDOTHELIAL ELECTRICAL RESISTANCE;

ADENOSINE; CELLS, CULTURED; CYCLIC AMP; CYTOSKELETON; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC IMPEDANCE; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GTP-BINDING PROTEIN ALPHA SUBUNITS; HUMANS; PERMEABILITY; PULMONARY ARTERY; RECEPTOR, ADENOSINE A2A; RNA, SMALL INTERFERING;

EID: 77950917821     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2009.12.008     Document Type: Article

References (62)

1. Allen-Gipson D.S., Wong J., Spurzem J.R., Sisson J.H., and Wyatt T.A. Adenosine A2A receptors promote adenosine-stimulated wound healing in bronchial epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 290 (2006) L849-L855
2. Allen-Gipson D.S., Spurzem K., Kolm N., Spurzem J.R., and Wyatt T.A. Adenosine promotion of cellular migration in bronchial epithelial cells is mediated by the activation of cyclic adenosine monophosphate-dependent protein kinase A. J. Investig. Med. 55 (2007) 378-385
3. Balestrieri M.L., Malik K.U., Balestrieri C., and Lee T.C. Types of purinoceptors and phospholipase A2 involved in the activation of the platelet-activating factor-dependent transacetylase activity and arachidonate release by ATP in endothelial cells. Prostaglandins Other Lipid Mediat. 56 (1998) 363-375
4. Birukova A.A., Smurova K., Birukov K.G., Kaibuchi K., Garcia J.G., and Verin A.D. Role of Rho GTPases in thrombin-induced lung vascular endothelial cells barrier dysfunction. Microvasc. Res. 67 (2004) 64-77
5. Bogatcheva, N.V., Verin, A.D., 2008. The role of cytoskeleton in the regulation of vascular endothelial barrier function. Microvasc. Res. 76 (3), 202-207 (Electronic publication ahead of print, 2008 Jun 28).
6. Brown R.A., Spina D., and Page C.P. Adenosine receptors and asthma. Br. J. Pharmacol. 153 (2008) S446-S456
7. Burnstock G. Potential therapeutic targets in the rapidly expanding field of purinergic signaling. Clin. Med. 91 (2003) 1487-1500
8. Csortos, C., Kolosova, I., Verin, A.D., 2007. Regulation of vascular endothelial cell barrier function and cytoskeleton structure by protein phosphatases of the PPP family. Am. J. Physiol. Lung Cell. Mol. Physiol. 293 (4), L843-L854.
9. Diwan A.H., Honkanen R.E., Schaeffer Jr. R.C., Strada S.J., and Thompson W.J. Inhibition of serine-threonine protein phosphatases decreases barrier function of rat pulmonary microvascular endothelial cells. J. Cell. Physiol. 171 (1997) 259-270
10. Dubey R.K., Gillespie D.G., Shue H., and Jackson E.K. A(2b) receptors mediate the antimitogenic effects of adenosine in cardiac fibroblasts. Hypertension 37 (2001) 716-721
11. Dudek, S.M., Garcia, J.G., 2001. Cytoskeletal regulation of pulmonary vascular permeability. J. Appl. Physiol. 91 (4), 1487-500.
12. Eckle T., Fllbier L., Wehrmann M., Khoury J., Mittelbronn M., Ibla J., Rosenberger P., and Eltzschig H.E. Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury. J. Immunol. 178 (2007) 8127-8137
13. Eckle T., Faigle M., Grenz A., Laucher S., Thompson L.F., and Eltzschig H.K. A2B adenosine receptor dampens hypoxia-induced vascular leak. Blood 111 (2008) 2024-2035
14. Eltzschig H.K., Thompson L.F., Karhausen J., Cotta R.J., Ibla J.C., Robson S.C., and Colgan S.P. Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism. Blood 104 (2004) 3986-3992
15. Essler M., Amano M., Kruse H.J., Kaibuchi K., Weber P.C., and Aepfelbacher M. Thrombin inactivates myosin light chain phosphatase via Rho and in target Rho kinase in human endothelial cells. J. Biol. Chem. 273 (1998) 21867-21574
16. Feng J., Ito M., Ichikawa K., Isaka N., Nishikawa M., Hartshorne D.J., and Nakano T. Inhibitory phosphorylation site for Rho-associated kinase on smooth muscle myosin phosphatase. J. Biol. Chem. 274 (1999) 37385-37390
17. Fredholm B.B., Irenius E., Kull B., and Schulte G. Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells. Biochem. Pharmacol. 61 (2001) 443-448
18. Fredholm B.B., Chen J.F., Cunha R.A., Svenningson P., and Vaugeois J.M. Adenosine and brain function. Int. Rev. Neurobiol. 63 (2005) 191-270
19. Gailly P., Wu X., Haystead T.A., Somlyo A.P., Cohen P.T., Cohen P., and Somlyo A.V. Regions of the 110-kDa regulatory subunit M110 required for regulation of myosin-light-chain-phosphatase activity in smooth muscle. Eur. J. Biochem. 239 (1996) 326-332
20. Gao Z., Chen T., Weber M.J., and Linden J. A2B adenosine and P2Y2 receptors stimulate mitogen-activated protein kinase in human embryonic kidney-293 cells. Cross-talk between cyclic AMP and protein kinase c pathways. J. Biol. Chem. 274 (1999) 5972-5980
21. Garcia J.G.N., and Schaphorst K.L. Regulation of endothelial cell gap formation and paracellular permeability. J. Invest. Med. 43 (1995) 117-126
22. Garcia J.G.N., Davis H.W., and Patterson C.E. Regulation of endothelial cell gap formation and barrier dysfunction. Role of myosin light chain phosphorylation. J. Cell. Physiol. 163 (1995) 510-522
23. Garcia G.E., Truong L.D., Li P., Zhang P., Du J., Chen J.F., and Feng L. Adenosine A2A receptor activation and macrophage-mediated experimental glomerulonephritis. FASEB J. 22 (2008) 445-454
24. Hamm H.E., and Glichrist A. Heterotrimeric G proteins. Curr. Opin. Cell Biol. 8 (1996) 189-196
25. Härtel F.V., Rodewald C.W., Aslam M., Gündüz D., Hafer L., Neumann J., Piper H.M., and Noll T. Extracellular ATP induces assembly and activation of the myosin light chain phosphatase complex in endothelial cells. Cardiovasc. Res. 74 (2007) 487-496
26. Hartshorne D.J., Ito M., and Erdodi F. Myosin light chain phosphatase; subunit composition, interactions and regulation. J. Muscle Res. Cell Motil. 19 (1998) 325-341
27. Haselton, F.R., Alexander, J.S., Mueller, S.N., 1993. Adenosine decreases permeability of in vitro endothelial monolayers. J. Appl. Physiol. 74 (4), 1581-1590.
28. Hasko G., and Cronstein B.N. Adenosine; an endogeneous regulator of innate immunity. Trends Immunol. 25 (2004) 33-39
29. Haskó G., and Pacher P. A2A receptors in inflammation and injury: lessons learned from transgenic animals. J. Leukoc. Biol. 83 (2008) 447-455
30. Ito M., Nakano T., Erdodi F., and Hartshorne D.J. Identification of protein-phosphatase-1-binding domains on the glycogen and myofibrillar targetting subunits. Mol. Cell. Biochem. 259 (2004) 197-209
31. Janiak A., Zemskov E.A., and Belkin A.M. Cell surface transglutaminase promotes RhoA activation via integrin clustering and suppression of the Src-p190RhoGAP signaling pathway. Mol. Biol. Cell 17 (2006) 1606-1619
32. Johnson D.F., Moorhead G., Caudwell F.B., Cohen P., Chen Y.H., Chen M.X., and Cohen P.T. Identification of protein-phosphatase-1-binding domains on the glycogen and myofibrillar targetting subunits. Eur. J. Biochem. 239 (1996) 317-325
33. Kimura K., Ito M., Amano M., Chihara K., Fukata Y., Nakafuku M., Yamamori B., Feng J., Nakano T., Okawa K., Iwamatsu A., and Kaibuchi K. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273 (1996) 245-248
34. Kolachala V.L., Bajaj R., Chalasani M., and Sitaraman S.V. Purinergic receptors in gastrointestinal inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 294 (2008) G401-G410
35. Kolosova I.A., Mirzapoiazova T., Adyshev D., Usatyuk P., Romer L.H., Jacobson J.R., Natarajan V., Pearse D.B., Garcia J.G., and Verin A.D. Signaling pathways involved in adenosine triphosphate-induced endothelial cell barrier enhancement. Circ. Res. 97 (2005) 115-124
36. Linden J. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu. Rev. Pharmacol. Toxicol. 41 (2001) 775-787
37. Liou G.I., Auchampach J.A., Hillard C.J., Zhu G., Yousufzai B., Mian S., Khan S., and Khalifa Y.M. Mediation of cannabidiol anti-inflammation in the retina by equilibrative nucleoside transporter and a2a adenosine receptor. Invest. Ophthalmol. Vis. Sci. 49 (2008) 5526-5531
38. Mickell C.C., and Curry F.E. Microvascular permeability. Physiol. Rev. 79 (1999) 703-761
39. Mohsenin A., Mi T., Xia Y., Kellems R.E., Chen J.F., and Blackburn M.R. Genetic removal of the A2A adenosine receptor enhances pulmonary inflammation, mucin production, and angiogenesis in adenosine deaminase-deficient mice. Am. J. Physiol. Lung Cell. Mol. Physiol 293 (2007) L753-L761
40. Morrison R.R., Tan X.L., Ledent C., Mustafa S.J., and Hofmann P.A. Targeted deletion of A2A adenosine receptors attenuates the protective effects of myocardial postconditioning. Am. J. Physiol. Heart Circ. Physiol. 293 (2007) H2523-H2529
41. Ohta A., and Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414 (2001) 916-920
42. Palmer T.M., and Trevethick M.A. Suppression of inflammatory and immune responses by the A(2A) adenosine receptor: an introduction. Br. J. Pharmacol. 153 Suppl 1 (2008) S27-S34
43. Paty, P.S., Sherman, P.F., Shepard, J.M., Malik, A.B., Kaplan, J.E., 1992. Role of adenosine in platelet-mediated reduction in pulmonary vascular permeability. Am. J. Physiol. 262 (3 Pt 2), H771-H777.
44. Pierce K.L., Premont R.T., and Lefkowitz R.J. Seven-transmembrane receptors. Nat. Rev. Mol. Cell. Biol 3 (2002) 639-650
45. Plagge A., Kelsey G., and Germain-Lee E.L. Physiological functions of the imprinted Gnas locus and its protein variants Galpha(s) and XLalpha(s) in human and mouse. J. Endocrinol. 96 (2008) 193-214
46. Polosa R.T., and Holgate S.T. Adenosine receptors as promising therapeutic targets for drug development in chronic airway inflammation. Curr. Drug Targets 7 (2006) 699-706
47. Rabinovitch P.S., Torres R.M., and Engel D. Simultaneous cell cycle analysis and two-color surface immunofluorescence using 7-amino-actinomycin D and single laser excitation: applications to study of cell activation and the cell cycle of murine Ly-1 B cells. J. Immunol. 136 (1986) 2769-2775
48. Reutershan J., Vollmer I., Stark S., Wagner R., Ngamsri K.C., and Eltzschig H.K. Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs. FASEB J. 23 (2009) 473-482
49. Satpathy M., Gallagher P., Jin Y., and Srinivas. Extracellular ATP opposes thrombin-induced myosin light chain phosphorylation and loss of barrier integrity in corneal endothelial cells. Exp. Eye Res. 81 (2005) 183-192
50. Scheibner, K.A., Boodoo, S., Collins, S., Black, K.E., Chan-Li, Y., Zarek, P., Powell, J.D., Horton, M.R., 2009. The adenosine a2a receptor inhibits matrix-induced inflammation in a novel fashion. Am. J. Respir. Cell Mol. Biol. 40 (3), 251-259.
51. Schnittler H.J., Wilke A., Gress T., Suttorp N., and Drenckhahn D. Role of actin and myosin in the control of paracellular permeability in pig, rat and human vascular endothelium. J. Physiol. 431 (1990) 379-401
52. Sitkovsky M.V., and Ohta A. The 'danger' sensors that STOP the immune response: the A2 adenosine receptors?. Trends Immunol. 26 (2005) 299-304
53. Stelzner T.J., Weil J.V., and O'Brien R.F. Role of cyclic adenosine monophosphate in the induction of endothelial barrier properties. J. Cell. Physiol. 139 (1989) 157-166
54. Takizawa N., Schmidt D.J., Mabuchi K., Villa-Moruzzi E., Tuft R.A., and Ikebe M. M20, the small subunit of PP1M, binds to microtubules. Am. J. Physiol. 284 (2003) C250-C262
55. Tar K., Birukova A.A., Csortos C., Bakó E., Garcia J.G., and Verin A.D. Phosphatase 2A is involved in endothelial cell microtubule remodeling and barrier regulation. J. Cell. Biochem 92 (2004) 534-546
56. Tar K., Csortos C., Czikora I., Olah G., Ma S.F., Wadgaonkar R., Gergely P., Garcia J.G., and Verin A.D. Role of protein phosphatase 2A in the regulation of endothelial cell cytoskeleton structure. J. Cell. Biochem. 98 (2006) 931-953
57. Thiel M., Chouker A., Ohta E., Jackson C., Caldwell P., Smith D., Lukashev I., Bittmann I., and Sitkovsky M.V. Oxygenation inhibits the physiological tissue-protecting mechanism and thereby exacerbates acute inflammatory lung injury. PLoS Biol. 3 (2005) e174
58. Thompson L.F., Eltzschig H.K., Ibla J.C., Van De Wiele C.J., Resta R., Morote-Garcia J.C., and Colgan S.P. Crucial role for ecto-5′-nucleotidase (CD73) in vascular leakage during hypoxia. J. Exp. Med. 200 (2004) 1395-1405
59. Tuma P.L., and Hubbardm A.L. Transcytosis: crossing cellular barriers. Physiol. Rev. 83 (2003) 871-932
60. Verin A.D., Patterson C.E., Day M.A., and Garcia J.G. Regulation of endothelial cell gap formation and barrier function by myosin-associated phosphatase activities. Am. J. Physiol. 269 (1995) L99-L108
61. Wilson C.N., and Batra V.K. Lipopolysaccharide binds to and activates A(1) adenosine receptors on human pulmonary artery endothelial cells. J. Endotoxin Res. 8 (2002) 263-271
62. Zimmermann H. Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch. Pharmacol. 362 (2000) 299-309